Safety Evaluation for Acute and Chronic Oral Toxicity of Maha Pigut Triphala Contains Three Medicinal Fruits in Sprague-Dawley Rats

Overview

Journal Biology (Basel)

Publisher MDPI

Specialty Biology

Date 2025 Jan 8

PMID 39765672

Authors

Supaporn Intatham

Weerakit Taychaworaditsakul

Parirat Khonsung

Sunee Chansakaow

Kanjana Jaijoy

Nirush Lertprasertsuke

Noppamas Soonthornchareonnon

Seewaboon Sireeratawong

Affiliations

Soon will be listed here.

Abstract

Maha Pigut Triphala is the herbal mixture of three fruits consisting of , , and also known as . Humans regularly eat the fresh fruits of these plants on a daily basis. Maha Pigut Triphala is one of the widely known herbal medicinal formulas used in traditional Thai medicine. Besides studying pharmacological properties, attention should also be paid to the safety and toxicity studies of herbal medicines. The objective of the present study was to evaluate the acute and chronic oral toxicity of Maha Pigut Triphala (2:1:3) in Sprague-Dawley rats. A single dose of Maha Pigut Triphala at a concentration of 5000 mg/kg body weight was administered orally to female rats in the acute oral toxicity study. In the chronic oral toxicity study, male and female rats were treated with various concentrations of Maha Pigut Triphala (600, 1200, and 2400 mg/kg body weight) once daily for 270 consecutive days. The presence of abnormalities in the symptoms and behavior of the rats were observed and recorded throughout the experiment. Additionally, body weight, organ weight, and mortality were recorded. At the end of the study, blood samples were collected for hematological and blood chemistry analysis, while the internal organs were evaluated for gross pathological and histopathological changes. The acute oral toxicity study revealed no mortality and abnormal symptoms or behavior in Maha Pigut Triphala-treated rats. Moreover, gross pathological and histopathological findings did not reveal any abnormalities in the internal organs. In the chronic oral toxicity evaluation, although there were negligible changes in body weight, organ weight, and hematological and blood chemistry parameters in rats treated with Maha Pigut Triphala for 270 days, no behavioral or gross pathological and histopathological abnormalities were observed. Overall, the results of this study demonstrate that Maha Pigut Triphala (2:1:3) neither causes acute nor chronic oral toxicity in rats, proposing the safety of this herbal formula in animals prior to human trials and use.

References

Kimura H, Sakai Y, Fujii T . Organ/body-on-a-chip based on microfluidic technology for drug discovery. Drug Metab Pharmacokinet. 2017; 33(1):43-48. DOI: 10.1016/j.dmpk.2017.11.003. View

Sookoian S, Pirola C . Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine. World J Gastroenterol. 2015; 21(3):711-25. PMC: 4299326. DOI: 10.3748/wjg.v21.i3.711. View

Chen J, Shi S, Liu G, Chen Y, Zheng S, Wang X . Potential Clinical Risk of Inflammation and Toxicity from Rare-Earth Nanoparticles in Mice. Chin Med J (Engl). 2018; 131(13):1591-1597. PMC: 6032687. DOI: 10.4103/0366-6999.235105. View

Hamoud A, Weaver L, Stec D, Hinds Jr T . Bilirubin in the Liver-Gut Signaling Axis. Trends Endocrinol Metab. 2018; 29(3):140-150. PMC: 5831340. DOI: 10.1016/j.tem.2018.01.002. View

Belapurkar P, Goyal P, Tiwari-Barua P . Immunomodulatory effects of triphala and its individual constituents: a review. Indian J Pharm Sci. 2015; 76(6):467-75. PMC: 4293677. View

Kajiyama H, Hamazaki T, Tokuhara M, Masui S, Okabayashi K, Ohnuma K . Pdx1-transfected adipose tissue-derived stem cells differentiate into insulin-producing cells in vivo and reduce hyperglycemia in diabetic mice. Int J Dev Biol. 2009; 54(4):699-705. DOI: 10.1387/ijdb.092953hk. View

Tsering J, Hu X . Triphala Suppresses Growth and Migration of Human Gastric Carcinoma Cells and in a Zebrafish Xenograft Model. Biomed Res Int. 2019; 2018:7046927. PMC: 6311269. DOI: 10.1155/2018/7046927. View

Fu K, Xu M, Zhou Y, Li X, Wang Z, Liu X . The Status quo and way forwards on the development of Tibetan medicine and the pharmacological research of tibetan materia Medica. Pharmacol Res. 2020; 155:104688. DOI: 10.1016/j.phrs.2020.104688. View

Suryavanshi S, Barve K, Utpat S, Kulkarni Y . Triphala churna ameliorates retinopathy in diabetic rats. Biomed Pharmacother. 2022; 148:112711. DOI: 10.1016/j.biopha.2022.112711. View

10.

Gupta A, Kumar R, Bhattacharyya P, Bishayee A, Pandey A . Terminalia bellirica (Gaertn.) roxb. (Bahera) in health and disease: A systematic and comprehensive review. Phytomedicine. 2020; 77:153278. DOI: 10.1016/j.phymed.2020.153278. View

11.

Arpornchayanon W, Subhawa S, Jaijoy K, Lertprasertsuk N, Soonthornchareonnon N, Sireeratawong S . Safety of the Oral Triphala Recipe from Acute and Chronic Toxicity Tests in Sprague-Dawley Rats. Toxics. 2022; 10(9). PMC: 9503284. DOI: 10.3390/toxics10090514. View

12.

Rana S, Palatty P, Benson R, Kochikuzhyil B, Baliga M . Evaluation of the anti-hyperlipidemic effects of in high fat diet fed rats: Studies with two combinations. Ayu. 2023; 43(3):98-104. PMC: 10710234. DOI: 10.4103/ayu.AYU_74_19. View

13.

Chittasupho C, Umsumarng S, Srisawad K, Arjsri P, Phongpradist R, Samee W . Inhibition of SARS-CoV-2-Induced NLRP3 Inflammasome-Mediated Lung Cell Inflammation by Triphala-Loaded Nanoparticle Targeting Spike Glycoprotein S1. Pharmaceutics. 2024; 16(6). PMC: 11206841. DOI: 10.3390/pharmaceutics16060751. View

14.

Mehmood M, Rehman A, Rehman N, Gilani A . Studies on prokinetic, laxative and spasmodic activities of Phyllanthus emblica in experimental animals. Phytother Res. 2012; 27(7):1054-60. DOI: 10.1002/ptr.4821. View

15.

Crissman J, Goodman D, Hildebrandt P, Maronpot R, Prater D, Riley J . Best practices guideline: toxicologic histopathology. Toxicol Pathol. 2004; 32(1):126-31. DOI: 10.1080/01926230490268756. View

16.

Prasad S, Srivastava S . Oxidative Stress and Cancer: Chemopreventive and Therapeutic Role of Triphala. Antioxidants (Basel). 2020; 9(1). PMC: 7022920. DOI: 10.3390/antiox9010072. View

17.

Peterson C, Denniston K, Chopra D . Therapeutic Uses of Triphala in Ayurvedic Medicine. J Altern Complement Med. 2017; 23(8):607-614. PMC: 5567597. DOI: 10.1089/acm.2017.0083. View

18.

Jagetia G, Baliga M, Malagi K, Sethukumar Kamath M . The evaluation of the radioprotective effect of Triphala (an ayurvedic rejuvenating drug) in the mice exposed to gamma-radiation. Phytomedicine. 2002; 9(2):99-108. DOI: 10.1078/0944-7113-00095. View

19.

Cordeiro M, Ribeiro A, de Melo L, da Silva L, Fidelis G, Silva L . Antioxidant Activities of (Mart.) J. B. Gillett) (Burseraceae) Leaf Extracts Using and Assays. Oxid Med Cell Longev. 2021; 2021:3043720. PMC: 8093066. DOI: 10.1155/2021/3043720. View

20.

Jayesh K, Karishma R, Vysakh A, Gopika P, Latha M . Terminalia bellirica (Gaertn.) Roxb fruit exerts anti-inflammatory effect via regulating arachidonic acid pathway and pro-inflammatory cytokines in lipopolysaccharide-induced RAW 264.7 macrophages. Inflammopharmacology. 2018; . DOI: 10.1007/s10787-018-0513-x. View